Superluminal Medicines, Inc.
Last verified 2026-05-08. JSON
| Total raised | $5.0M |
|---|---|
| Latest round | Funding round, $5.0M, 2025-08-26 |
| Founded | unknown |
| Headquarters | BOSTON, MA |
| Industry | bio |
| Stage | unknown |
| Website | superluminalmedicines.com |
Biotechnology company based in BOSTON, MA
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-08-26 | Funding round | $5.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $5.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $5.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | superluminalmedicines.com, read 2026-05-08 |
| Description | self-reported | superluminalmedicines.com, read 2026-05-08 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $5.0M, 2025-08-26 → Funding round, $5.0M, 2025-08-26, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $5.0M, 2025-08-26 → Funding round, $5.0M, 2025-08-26 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes